Caroline Dorsa Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Caroline Dorsa is Director of Intellia Therapeutics, Inc.. Currently has a direct ownership of 12,701 shares of NTLA, which is worth approximately $181,624. The most recent transaction as insider was on Jun 14, 2022, when has been sold 5,197 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.7K
0% 3M change
0% 12M change
Total Value Held $181,624

CAROLINE DORSA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2022
BUY
Grant, award, or other acquisition
-
5,197 Added 29.04%
12,701 Common Stock
Jun 23 2021
BUY
Grant, award, or other acquisition
-
2,094 Added 50.0%
2,094 Common Stock
Apr 05 2021
SELL
Open market or private sale
$617,100 $82.28 p/Share
7,500 Reduced 58.09%
5,410 Common Stock
Apr 05 2021
BUY
Exercise of conversion of derivative security
$48,000 $6.4 p/Share
7,500 Added 36.75%
12,910 Common Stock

Also insider at

DUK
Duke Energy CORP Utilities
Director
ILMN
ILLUMINA, INC. Healthcare
Director
BIIB
BIOGEN INC. Healthcare
Director
CD

Caroline Dorsa

Director
Charlotte, NC

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA